Unipharm
Generic Drug Manufacturing
Startup Mature Health Tech & Life Sciences Est. 1975
Total Raised
Undisclosed
Mature
Last Round
Undisclosed
Team
3
51-200 employees
Confidence
98/100
Patents
1
About
Unipharm develops, manufactures, and markets generic pharmaceuticals. The company offers a product portfolio consisting of a broad range of high-quality generic pharmaceuticals for all major therapeutic areas, including mental health, heart health, sleep drugs, Alzheimers disease, osteoporosis, infectious diseases, urology, and ophthalmology. The drugs are manufactured by Unipharms new, EU-GMP-certified manufacturing plant at Mavo Carmel Industrial Park, Israel. Unipharm was founded by Zvulun Tomer in 1975.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
Materials & Substances
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2BB2C
Tags
mental-healthneurologycardiologyalzheimers-diseasegeneric-drugspharmaceuticalsophthalmologypharma-companies
Details
Product Stage
Released
Employees
51-200
Exact Count
116
District
Center District
Founded
1975
Registrar
510457666
Crunchbase
unipharm-israel
Locations
Shevet Shim'on Street 1, Tel Aviv, Israel
Links
Website
LinkedIn
Facebook
Admin
Last Update
Sep 28, 2024
Verified by
Jenny Sotnik-Talisman
Missing
funding rounds, news, markets
Team (3)
Ron Tomer
Co-CEO
Gil Tomer
Co-CEO
Einat Cohen- Tzedek
HR Manager
Internal
Created by
Natalia Golczar (ngolczar@gmail.com)
Created
2017-12-20T00:00:00.000Z
Last editor
Orli Wollner (orlushka@gmail.com)